University of Texas Southwestern Medical Center (UT Southwestern)

Impact of Oral Semaglutide on Kidney Outcomes in People With Type 2 Diabetes: Results From the SOUL Randomized Trial. Diabetes Care 2026;49:257–265 (2026) Mann JF, Jeppesen OK, Belmar N, McGuire DK, Buse JB Journal article Effect of Oral Semaglutide on Cardiovascular Outcomes in Type 2 Diabetes by Extent of Vascular Disease (2026) Cavender MA, Marx N, Mulvagh SL, Deanfield JE, Buse JB, Inzucchi SE, Pop-Busui R, et al. Journal article Immune checkpoint inhibitor-associated myocarditis: A novel risk score (2026) Power JR, Dolladille C, Ozbay B, Procureur A, Ederhy S, Palaskas NL, Lehmann LH, et al. Journal article Impact of Oral Semaglutide on Kidney Outcomes in People With Type 2 Diabetes: Results From the SOUL Randomized Trial (2026) Mann JF, Marx N, Deanfield JE, Emerson SS, Inzucchi SE, McGuire DK, Mulvagh SL, et al. Journal article Surgical Outcomes After Neoadjuvant Pembrolizumab Plus Chemotherapy for Triple-Negative Breast Cancer: Results from the Randomized, Placebo-Controlled Phase 3 KEYNOTE-522 Study (2026) Kuemmel S, Fasching P, Schmid P, Harbeck N, Takahashi M, Untch M, Boileau JF, et al. Journal article Oral Semaglutide and Heart Failure Outcomes in Persons With Type 2 Diabetes (2026) Pop-Busui R, Rasmussen S, Deanfield JE, Buse JB, Marx N, Mulvagh SL, Inzucchi SE, et al. Journal article Noise in the diagnosis of epilepsy by experts (2026) Nascimento FA, McLaren JR, Zhao W, Katyal R, Sheikh IS, Kong WY, Aljaafari D, et al. Journal article Fenestrating Adenocarcinoma: A Novel Salivary Gland Cancer With EWSR1::BEND2 Fusion and Predilection for the Pharynx (2026) Al-Sajee D, Rooper LM, Bishop JA, Bell D, Dogan S, Xu B, Raja S, et al. Journal article Semaglutide and Cardiovascular Outcomes According to Baseline Aspirin Use: Analyses of the SOUL and SELECT Trials (2026) Müller-Wieland D, McGuire DK, Lincoff AM, Buse JB, Mann JF, Inzucchi SE, Pop-Busui R, et al. Journal article Acute eGFR Changes and Their Mediation of Albuminuria Reduction with Empagliflozin and Finerenone (2026) Agarwal R, Correa-Rotter R, Navaneethan SD, Fukami K, Heerspink HJ, Mann JF, McGill JB, et al. Journal article